Skip to main content
Erschienen in: Cancer Causes & Control 10/2010

01.10.2010 | Original paper

Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006

verfasst von: Anne Marie McCarthy, Tamara Dumanovsky, Kala Visvanathan, Amy R. Kahn, Maria J. Schymura

Erschienen in: Cancer Causes & Control | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Though cervical cancer rates have declined due to Pap screening, racial and socioeconomic disparities in cervical cancer incidence and mortality persist. This study assesses the relative impact of race/ethnicity and neighborhood poverty on cervical cancer incidence and mortality in New York City (NYC).

Methods

Invasive cervical cancer cases in NYC from 1995 to 2006 were identified along with demographic and socioeconomic measures. Odds ratios (OR) of late stage diagnosis were estimated using logistic regression. Hazard ratios (HR) of death were calculated using Cox proportional hazards regression.

Results

From 1995 to 2006 cervical cancer incidence and mortality rates decreased in NYC, though black and Hispanic women had higher incidence and mortality rates than white women. Puerto Ricans (OR = 1.55, 95% CI = 1.20–2.01) and blacks (OR = 1.34, 95% CI = 1.15–1.57) were more likely to be diagnosed with late stage disease than whites. In multivariate analysis, blacks had similar mortality risk (HR 1.07, 95% CI = 0.95–1.20) to whites while Puerto Ricans had increased risk (HR = 1.31, 95% CI = 1.10–1.55), and non-Puerto Rican Hispanics (HR = 0.54, 95% CI = 0.45–0.63) and Asian/PIs (HR = 0.64, 95% CI = 0.52–0.78) had reduced risk. Women living in high poverty neighborhoods had higher mortality than women in higher income neighborhoods (HR = 1.32, 95% CI = 1.16–1.52).

Conclusions

Black and Puerto Rican women in NYC are at greatest risk of dying from cervical cancer. Race/ethnicity is predictive of late stage diagnosis, while both race/ethnicity and neighborhood poverty are important predictors of cervical cancer mortality.
Literatur
1.
Zurück zum Zitat American Cancer Society (2008) Cancer facts and figures American Cancer Society (2008) Cancer facts and figures
2.
Zurück zum Zitat Garner EIO (2003) Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12(3):242s–247PubMed Garner EIO (2003) Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12(3):242s–247PubMed
3.
Zurück zum Zitat Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlander N, Horner M et al. (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER website 2008; Available at: http://seer.cancer.gov/csr/1975_2005/. Accessed 08, 2008 Ries L, Melbert D, Krapcho M, Stinchcomb D, Howlander N, Horner M et al. (2008) SEER cancer statistics review, 1975–2005. National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER website 2008; Available at: http://​seer.​cancer.​gov/​csr/​1975_​2005/​. Accessed 08, 2008
4.
Zurück zum Zitat del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E (1999) Ethnic differences in patterns of care of Stage 1A1 and Stage 1A2 cervical cancer: A SEER database study. Gynecologic Oncol 75(1):113–117CrossRef del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E (1999) Ethnic differences in patterns of care of Stage 1A1 and Stage 1A2 cervical cancer: A SEER database study. Gynecologic Oncol 75(1):113–117CrossRef
5.
Zurück zum Zitat Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecologic Oncol 109(2, Suppl 1):S22–S30 Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecologic Oncol 109(2, Suppl 1):S22–S30
6.
Zurück zum Zitat Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357 Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94(5):334–357
7.
Zurück zum Zitat Karpati A, Kerker B, Mostashari F, Singh T, Hajat A, Thorpe L et al (2004) Health disparities in New York City. New York City Department of Health and Mental Hygiene, New York Karpati A, Kerker B, Mostashari F, Singh T, Hajat A, Thorpe L et al (2004) Health disparities in New York City. New York City Department of Health and Mental Hygiene, New York
8.
Zurück zum Zitat Kerker B, Kim M, Mostashari F, Thorpe L, Friedan T (2005) Women at risk: the health of women in New York City. New York City Department of Health and Mental Hygiene, New York Kerker B, Kim M, Mostashari F, Thorpe L, Friedan T (2005) Women at risk: the health of women in New York City. New York City Department of Health and Mental Hygiene, New York
9.
Zurück zum Zitat Wang JH, Sheppard VB, Schwartz MD, Liang W, Mandelblatt JS (2008) Disparities in cervical cancer screening between Asian American and Non-Hispanic White women. Cancer Epidemiol Biomark Prev 17(8):1968–1973CrossRef Wang JH, Sheppard VB, Schwartz MD, Liang W, Mandelblatt JS (2008) Disparities in cervical cancer screening between Asian American and Non-Hispanic White women. Cancer Epidemiol Biomark Prev 17(8):1968–1973CrossRef
10.
Zurück zum Zitat Klein RJ, Schoenborn CA (2001) Age adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes, no. 20. National Center for Health Statistics, Hyattsville, MD Klein RJ, Schoenborn CA (2001) Age adjustment using the 2000 projected U.S. population. Healthy People Statistical Notes, no. 20. National Center for Health Statistics, Hyattsville, MD
11.
Zurück zum Zitat Efron B (1977) The efficiency of Cox’s likelihood function for censored data. J Am Stat Ass 72:557–565CrossRef Efron B (1977) The efficiency of Cox’s likelihood function for censored data. J Am Stat Ass 72:557–565CrossRef
12.
Zurück zum Zitat Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ (2001) Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154(6):544–556CrossRefPubMed Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ (2001) Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154(6):544–556CrossRefPubMed
13.
Zurück zum Zitat Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31(3):157–181CrossRefPubMed Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31(3):157–181CrossRefPubMed
14.
Zurück zum Zitat Bates JH, Hofer BM, Parikh-Patel A (2008) Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 113(10):2955–2963CrossRefPubMed Bates JH, Hofer BM, Parikh-Patel A (2008) Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 113(10):2955–2963CrossRefPubMed
15.
Zurück zum Zitat Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG et al. (2005) Annual report to the Nation on the Status of Cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427 Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG et al. (2005) Annual report to the Nation on the Status of Cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407–1427
16.
Zurück zum Zitat Zapka JG, Taplin SH, Solberg LI, Manos MM (2003) A framework for improving the quality of cancer care. Cancer Epidemiol Biomarkers Prev 12(1):4–13PubMed Zapka JG, Taplin SH, Solberg LI, Manos MM (2003) A framework for improving the quality of cancer care. Cancer Epidemiol Biomarkers Prev 12(1):4–13PubMed
17.
Zurück zum Zitat Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J (2003) Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 60(3):294–331 Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J (2003) Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 60(3):294–331
18.
Zurück zum Zitat Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMed Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297(8):813–819CrossRefPubMed
19.
Zurück zum Zitat Spence AR, Goggin P, Franco EL (2007) Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 45(2–3):93–106CrossRefPubMed Spence AR, Goggin P, Franco EL (2007) Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med 45(2–3):93–106CrossRefPubMed
20.
Zurück zum Zitat Olson E, Van Wye G, Kerker B, Thorpe L (2006) Cervical cancer screening in New York City. NYC Vital Signs 5(3):1–4 Olson E, Van Wye G, Kerker B, Thorpe L (2006) Cervical cancer screening in New York City. NYC Vital Signs 5(3):1–4
21.
Zurück zum Zitat Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004) Some methodologic lessons learned from cancer screening research. Cancer 101(S5):1131–1145 Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004) Some methodologic lessons learned from cancer screening research. Cancer 101(S5):1131–1145
22.
Zurück zum Zitat Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: Findings from the SEER–Medicare linked data cohorts. Gynecol Oncol 102(2):278–284 Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: Findings from the SEER–Medicare linked data cohorts. Gynecol Oncol 102(2):278–284
23.
Zurück zum Zitat Johnson CE, Mues KE, Mayne SL, Kiblawi AN (2008) Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the health belief model. J Lower Genital Tract Disease 12(3):232–241CrossRef Johnson CE, Mues KE, Mayne SL, Kiblawi AN (2008) Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the health belief model. J Lower Genital Tract Disease 12(3):232–241CrossRef
24.
Zurück zum Zitat Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W (2005) Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 105(6):1323–1328PubMed Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W (2005) Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet Gynecol 105(6):1323–1328PubMed
25.
Zurück zum Zitat Newmann SJ, Garner EO (2005) Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16(1):63–70CrossRefPubMed Newmann SJ, Garner EO (2005) Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16(1):63–70CrossRefPubMed
26.
Zurück zum Zitat Patel DA, Barnholtz-Sloan JS, Patel MK, Malone J, John M, Chuba PJ, Schwartz K (2005) A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of surveillance, epidemiology, and end results data. Gynecol Oncol 97(2):550–558CrossRefPubMed Patel DA, Barnholtz-Sloan JS, Patel MK, Malone J, John M, Chuba PJ, Schwartz K (2005) A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of surveillance, epidemiology, and end results data. Gynecol Oncol 97(2):550–558CrossRefPubMed
27.
Zurück zum Zitat Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR (2006) Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995–2001. J Women’s Health 15(8):941–951CrossRef Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR (2006) Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995–2001. J Women’s Health 15(8):941–951CrossRef
28.
Zurück zum Zitat Leath III CA, Straughn J, Michael J, Kirby TO, Huggins A, Partridge EE, Parham GP (2005) Predictors of outcomes for women with cervical carcinoma. Gynecologic Oncol 99(2):432–436 Leath III CA, Straughn J, Michael J, Kirby TO, Huggins A, Partridge EE, Parham GP (2005) Predictors of outcomes for women with cervical carcinoma. Gynecologic Oncol 99(2):432–436
29.
Zurück zum Zitat Thoms W, Unger E, Johnson P, Spann C, Hunter S, Smith R et al (1995) Cervical cancer survival in a high risk urban population. Cancer 76(12):2518–2523CrossRefPubMed Thoms W, Unger E, Johnson P, Spann C, Hunter S, Smith R et al (1995) Cervical cancer survival in a high risk urban population. Cancer 76(12):2518–2523CrossRefPubMed
30.
Zurück zum Zitat Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG (2009) Disparities in survival among women with invasive cervical cancer. Cancer 115(1):166–178CrossRefPubMed Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG (2009) Disparities in survival among women with invasive cervical cancer. Cancer 115(1):166–178CrossRefPubMed
31.
Zurück zum Zitat Movva S, Noone A, Banerjee M, Patel D, Schwartz K, Yee C et al (2008) Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 112(6):1264–1271CrossRefPubMed Movva S, Noone A, Banerjee M, Patel D, Schwartz K, Yee C et al (2008) Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 112(6):1264–1271CrossRefPubMed
32.
Zurück zum Zitat Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057CrossRefPubMed Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057CrossRefPubMed
33.
Zurück zum Zitat Lin S, Clarke C, Prehn A, Glaser S, West D, O’Malley C (2002) Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer 94(4):1175–1182CrossRefPubMed Lin S, Clarke C, Prehn A, Glaser S, West D, O’Malley C (2002) Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas. Cancer 94(4):1175–1182CrossRefPubMed
34.
Zurück zum Zitat Abraído-Lanza AF, Chao MT, Flórez KR (2005) Do healthy behaviors decline with greater acculturation?: implications for the Latino mortality paradox. Soc Sci Med 61(6):1243–1255 Abraído-Lanza AF, Chao MT, Flórez KR (2005) Do healthy behaviors decline with greater acculturation?: implications for the Latino mortality paradox. Soc Sci Med 61(6):1243–1255
35.
Zurück zum Zitat Lobo AP, Flores RJO, Salvo JJ (2002) The impact of Hispanic growth on the racial/ethnic composition of New York City neighborhoods. Urban Aff Rev 37(5):703–727 Lobo AP, Flores RJO, Salvo JJ (2002) The impact of Hispanic growth on the racial/ethnic composition of New York City neighborhoods. Urban Aff Rev 37(5):703–727
36.
Zurück zum Zitat Lara M, Gamboa C, Kahramanian MI, Morales LS, Hayes Bautista DE (2005) Acculturation and latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health 26(1):367–397 Lara M, Gamboa C, Kahramanian MI, Morales LS, Hayes Bautista DE (2005) Acculturation and latino health in the United States: a review of the literature and its sociopolitical context. Annu Rev Public Health 26(1):367–397
37.
Zurück zum Zitat Singh G, Miller B, Hankey B, Edwards B (2004) Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057 Singh G, Miller B, Hankey B, Edwards B (2004) Persistent area socioeconomic disparities in US incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 101(5):1051–1057
38.
Zurück zum Zitat Krieger N, Chen JT, Waterman PD, Soobader M, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the public health disparities geocoding project. Am J Epidemiol 156(5):471–482 Krieger N, Chen JT, Waterman PD, Soobader M, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the public health disparities geocoding project. Am J Epidemiol 156(5):471–482
Metadaten
Titel
Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995–2006
verfasst von
Anne Marie McCarthy
Tamara Dumanovsky
Kala Visvanathan
Amy R. Kahn
Maria J. Schymura
Publikationsdatum
01.10.2010
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2010
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9593-7

Weitere Artikel der Ausgabe 10/2010

Cancer Causes & Control 10/2010 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.